138 related articles for article (PubMed ID: 11494233)
121. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
122. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
Shin KH; Shin JH; Kim JH; Park JG
Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
[TBL] [Abstract][Full Text] [Related]
123. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
Chai SM; Zeps N; Shearwood AM; Grieu F; Charles A; Harvey J; Goldblatt J; Joseph D; Iacopetta B
Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1017-25. PubMed ID: 15551255
[TBL] [Abstract][Full Text] [Related]
124. [Colorectal carcinoma in consideration of the new German S3 guideline 2013].
Neumann JH; Kirchner T
Pathologe; 2014 Nov; 35(6):615-21; quiz 622-3. PubMed ID: 25106124
[TBL] [Abstract][Full Text] [Related]
125. [Genetic abnormality of hereditary nonpolyposis colorectal cancer and implication of clinical application].
Baba S
Nihon Shokakibyo Gakkai Zasshi; 2000 Aug; 97(8):1017-24. PubMed ID: 10965759
[No Abstract] [Full Text] [Related]
126. DNA mismatch repair status may influence anti-neoplastic effects of butyrate.
Coxhead JM; Williams EA; Mathers JC
Biochem Soc Trans; 2005 Aug; 33(Pt 4):728-9. PubMed ID: 16042586
[TBL] [Abstract][Full Text] [Related]
127. The case for surveillance of high-risk' families.
Dunlop MG
Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):229-33. PubMed ID: 9585026
[TBL] [Abstract][Full Text] [Related]
128. Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer.
Benatti P; Roncucci L; Ganazzi D; Percesepe A; Di Gregorio C; Pedroni M; Borghi F; Sala E; Scarselli A; Menigatti M; Rossi G; Genuardi M; Viel A; Ponz De Leon M
Int J Cancer; 2001 Sep; 95(5):323-8. PubMed ID: 11494233
[TBL] [Abstract][Full Text] [Related]
129. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
Kouraklis G; Misiakos EP
Dig Dis Sci; 2005 Feb; 50(2):336-44. PubMed ID: 15745097
[TBL] [Abstract][Full Text] [Related]
130. Molecular basis of HNPCC: mutations of MMR genes.
Papadopoulos N; Lindblom A
Hum Mutat; 1997; 10(2):89-99. PubMed ID: 9259192
[TBL] [Abstract][Full Text] [Related]
131. DNA mismatch repair defects: role in colorectal carcinogenesis.
Jacob S; Praz F
Biochimie; 2002 Jan; 84(1):27-47. PubMed ID: 11900875
[TBL] [Abstract][Full Text] [Related]
132. [Identification and genetic counseling of people with HNPCC (hereditary nonpolyposis colorectal cancer): old and new research goals].
Müller H; Dobbie Z; Heinimann K
Schweiz Med Wochenschr; 1999 Dec; 129(50):1978-85. PubMed ID: 10637951
[TBL] [Abstract][Full Text] [Related]
133. [Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?].
Rüschoff J; Dietmaier W; Bocker T; Wallinger S; Kullmann F; Beham A; Hofstädter F
Pathologe; 1998 Jul; 19(4):269-78. PubMed ID: 9746911
[TBL] [Abstract][Full Text] [Related]
134.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
135.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
136.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
137.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
138.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
